On behalf of the Controlled Release Society BeNeLux & France Local Chapter’s (CRS BNLF) Early Career Scientist Committee, we invite you to join us for the Early Career Scientist (ECS) Meeting 2021.
The ECS Meeting is specifically dedicated to PhD students and postdocs, providing them with an opportunity to present their research and network with international peers. Due to the COVID-19 pandemic, this will be a virtual event. Nevertheless, we aim to host a dynamic event with plenty of interactions between young scientists.
The ECS Meeting will include keynote lectures by leading drug delivery scientists from academia and industry. Early career scientists are invited to submit abstracts and present their research in a short presentations or pitch. The best presentation and pitch are awarded with a prize!
Two people with the best presentation and pitch will be awarded with 50% discount on article processing charges for a Special Issue of Frontiers in Medical Technology!
Throughout the Meeting, time will also be dedicated to informal and entertaining activities that we hope will boost networking! Importantly, the event can be attended free of charge after registration.
We look forward to seeing you at the CRS BNLF ECS Meeting in April!
You can submit an abstract which can be either presented as:
Below you will find the guidelines to prepare your abstract for submission:
1. Template: Download the word template here. Do not change the headings, font or font size.
3. Your abstract should be sent to firstname.lastname@example.org as word document. Please indicate if your abstract should be considered to oral presentation, pitch or both. The subject of the email should be ‘Abstract Submission: CRS BNLF ECS Meeting’.
4. Deadline for submission: March 6th, 2021.
5. Abstract submissions may be withdrawn until March 6th, 2021
Process for Abstract Selection
The abstract will be evaluated by the CRS BNLF Scientific Committee and will be assigned a rank order based on its scientific content. Abstracts will be rejected if they do not comply with submission guidelines. Selected abstracts that were submitted for both oral presentation and pitch will be assigned to one of them.
The presenting author will be notified of the abstract status on March 20th, 2021.